找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Antibody Therapy; Substitution – Immun Paul Imbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Immunoglobu

[復(fù)制鏈接]
樓主: Animosity
41#
發(fā)表于 2025-3-28 14:53:37 | 只看該作者
Einführung in die theoretische Gasdynamikin practical clinical science. Substitutive administration of a new concentrate of a human immunoglobulin (IgG) preparation resulted in regular minimal platelet increases in a child with a primary immunodeficiency and low platelet counts despite normal platelet production. The investigators conclude
42#
發(fā)表于 2025-3-28 22:41:14 | 只看該作者
Einführung in die theoretische Gasdynamikestones in the history of human immunoglobulins since the initial observation by Ogden C. Bruton who described replacement therapy in a single boy with agammaglobulinemia. Since then, the preparations used for treatment have been markedly improved with respect to tolerability, clinical efficacy, and
43#
發(fā)表于 2025-3-28 23:11:57 | 只看該作者
44#
發(fā)表于 2025-3-29 04:24:39 | 只看該作者
Kapitel 7: Erfassung sozialer Ph?nomeneoimmune syndromes. Although the precise mechanism of action of IVIg as an immunomodulatory agent has been elusive, many theories over the years have been postulated. These theories include mononuclear phagocytic system blockade, autoantibody neutralization, increased clearance of pathogenic autoanti
45#
發(fā)表于 2025-3-29 08:53:31 | 只看該作者
46#
發(fā)表于 2025-3-29 15:11:12 | 只看該作者
Kapitel 10: Theorien der Gegenwartously untreatable, or poorly managed, conditions. Based on controlled trials, IVIg is approved as first-line therapy for patients with GBS, CIDP, and multifocal motor neuropathy. In CIDP, where the largest controlled study was performed, IVIg is also effective in the chronic management of the diseas
47#
發(fā)表于 2025-3-29 18:47:07 | 只看該作者
Kapitel 6: Grundbegriffe und Datenerhebungwhen Furusho et al. (1984) and Newburger et al. (1986), respectively, reported the successful application of IVIg in Kawasaki syndrome. Seven years later, Dalakas et al. (1993) reported the first successful randomized controlled trial of IVIg in the treatment of dermatomyositis. Ever since, IVIg has
48#
發(fā)表于 2025-3-29 23:13:03 | 只看該作者
49#
發(fā)表于 2025-3-30 02:25:00 | 只看該作者
50#
發(fā)表于 2025-3-30 04:39:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-22 18:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
治县。| 文水县| 碌曲县| 晋中市| 峨眉山市| 容城县| 光泽县| 铜梁县| 英德市| 垫江县| 惠来县| 饶阳县| 信宜市| 太谷县| 光山县| 台中县| 巫山县| 山丹县| 东山县| 利辛县| 南木林县| 桃江县| 涞水县| 邵阳县| 伊宁县| 荣成市| 呈贡县| 赤城县| 仁化县| 灵山县| 同德县| 阳原县| 大同县| 芦溪县| 海口市| 安龙县| 寿阳县| 望奎县| 枣阳市| 贵港市| 长垣县|